These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 9347201

  • 1. The effect of flumazenil on subclinical psychometric or neurophysiological alterations in cirrhotic patients: a double-blind placebo-controlled study.
    Amodio P, Marchetti P, Del Piccolo F, Beghi A, Comacchio F, Carraro P, Campo G, Baruzzo L, Marchiori C, Gatta A.
    Clin Physiol; 1997 Sep; 17(5):533-9. PubMed ID: 9347201
    [Abstract] [Full Text] [Related]

  • 2. Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial.
    Pomier-Layrargues G, Giguère JF, Lavoie J, Perney P, Gagnon S, D'Amour M, Wells J, Butterworth RF.
    Hepatology; 1994 Jan; 19(1):32-7. PubMed ID: 8276366
    [Abstract] [Full Text] [Related]

  • 3. Visual event-related potentials in cirrhotic patients without overt encephalopathy: the effects of flumazenil.
    Jones EA, Giger-Mateeva VI, Reits D, Riemslag FC, Liberov B, Spekrijse H.
    Metab Brain Dis; 2001 Jun; 16(1-2):43-53. PubMed ID: 11726088
    [Abstract] [Full Text] [Related]

  • 4. Flumazenil in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double blind randomized placebo controlled study.
    Laccetti M, Manes G, Uomo G, Lioniello M, Rabitti PG, Balzano A.
    Dig Liver Dis; 2000 May; 32(4):335-8. PubMed ID: 11515632
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Flumazenil for hepatic coma in patients with liver cirrhosis: an Italian multicentre double-blind, placebo-controlled, crossover study.
    Barbaro G, Di Lorenzo G, Soldini M, Marziali M, Bellomo G, Belloni G, Grisorio B, Annese M, Bacca D, Barbarini G.
    Eur J Emerg Med; 1998 Jun; 5(2):213-8. PubMed ID: 9846248
    [Abstract] [Full Text] [Related]

  • 7. Evoked potentials and the effect of flumazenil in patients with liver cirrhosis.
    Ozyilkan E, Kahraman H, Onar M, Kesim G, Arik Z.
    East Afr Med J; 1997 Apr; 74(4):210-2. PubMed ID: 9299818
    [Abstract] [Full Text] [Related]

  • 8. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study.
    Barbaro G, Di Lorenzo G, Soldini M, Giancaspro G, Bellomo G, Belloni G, Grisorio B, Annese M, Bacca D, Francavilla R, Barbarini G.
    Hepatology; 1998 Aug; 28(2):374-8. PubMed ID: 9695999
    [Abstract] [Full Text] [Related]

  • 9. Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: a double-blind pragmatic randomized, placebo study.
    Cadranel JF, el Younsi M, Pidoux B, Zylberberg P, Benhamou Y, Valla D, Opolon P.
    Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):325-9. PubMed ID: 7600138
    [Abstract] [Full Text] [Related]

  • 10. Benzodiazepine receptor antagonism improves reaction time in latent hepatic encephalopathy.
    Gooday R, Hayes PC, Bzeizi K, O'Carroll RE.
    Psychopharmacology (Berl); 1995 Jun; 119(3):295-8. PubMed ID: 7675964
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effect of flumazenil on visual event-related potentials of clinically non-encephalopathic patients with cirrhosis.
    Giger-Mateeva VI, Reits D, Liberov B, Jones EA, Spekreijse H.
    Neurosci Lett; 1999 Dec 10; 276(3):173-6. PubMed ID: 10612633
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Benzodiazepine receptor antagonists for acute and chronic hepatic encephalopathy.
    Als-Nielsen B, Kjaergard LL, Gluud C.
    Cochrane Database Syst Rev; 2001 Dec 10; (4):CD002798. PubMed ID: 11687160
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Diazepam-induced disruption of classically-conditioned fear-potentiation of late-latency auditory evoked potentials is prevented by flumazenil given before, but not after, CS/US pairing.
    Scaife JC, Hou RH, Samuels ER, Baqui F, Langley RW, Bradshaw CM, Szabadi E.
    J Psychopharmacol; 2007 Jan 10; 21(1):93-101. PubMed ID: 16533870
    [Abstract] [Full Text] [Related]

  • 19. Flumazenil therapy for hepatic encephalopathy. A double-blind cross over study.
    Van der Rijt CC, Schalm SW, Meulstee J, Stijnen T.
    Gastroenterol Clin Biol; 1995 Jan 10; 19(6-7):572-80. PubMed ID: 7590022
    [Abstract] [Full Text] [Related]

  • 20. Do benzodiazepine ligands contribute to hepatic encephalopathy?
    Jones EA, Basile AS, Yurdaydin C, Skolnich P.
    Adv Exp Med Biol; 1993 Jan 10; 341():57-69. PubMed ID: 8116487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.